P8IP
HALO icon

Pier 88 Investment Partners’s Halozyme HALO Stock Holding History

Pier 88 Investment Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Sell
19,000
-280
-1% -$19.7K 0.31% 43
2025
Q4 		$1.3M Sell
19,280
-780
-4% -$52.5K 0.29% 42
2025
Q3 		$1.47M Buy
20,060
+9,540
+91% +$634K 0.28% 41
2025
Q2 		$547K Buy
10,520
+2,570
+32% +$146K 0.1% 83
2025
Q1 		$507K Buy
+7,950
New +$462K 0.1% 85

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pier 88 Investment Partners's HALO Position: Q1 2026 in Review

Pier 88 Investment Partners reduced its Halozyme (HALO) stake by 1.5% in Q1 2026, selling an estimated $19.7K and leaving 19,000 shares worth $1.23M. The position accounts for 0.31% of the portfolio, ranked #43.

Pier 88 Investment Partners first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.47M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Pier 88 Investment Partners held 19,000 shares of Halozyme worth $1.23M as of Q1 2026.
  • Pier 88 Investment Partners sold 280 Halozyme shares in Q1 2026, an estimated $19.7K.
  • Halozyme made up 0.31% of Pier 88 Investment Partners's portfolio in Q1 2026, its #43 holding.
  • Pier 88 Investment Partners first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • Pier 88 Investment Partners's Halozyme position peaked at $1.47M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Pier 88 Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.